Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer.
Journal Information
Full Title: Front Oncol
Abbreviation: Front Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"supplementary table 2 presents information about the antibodies used for immunohistochemistry 2 13 all data"
"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Jiangsu 333 Talent Fund (BRA2020016), China International Medical Exchange Fund(Z-2014-06-2104), Zhenjiang 169 Talent Project Scientific Research Project (2021-169-XX-19), Zhenjiang Key Research and Development Fund (SH2021038, SH2022032), Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_3766)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025